Want to see IN:AJOONI full AI Analyst Report?
AJOONI Stock Chart & Stats
₹5.13
₹0.07(0.90%)
At close: 4:00 PM EST
₹5.13
₹0.07(0.90%)
Day’s Range― - ―
52-Week Range₹3.02 - ₹5.57
Previous CloseN/A
Volume422.93K
Average Volume (3M)371.61K
Market Cap
₹547.73M
Enterprise Value₹897.51
Total Cash (Recent Filing)₹3.74M
Total Debt (Recent Filing)₹269.11M
Price to Earnings (P/E)14.2
Beta1.12
Next Earnings
Nov 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.22
Shares Outstanding172,243,590
10 Day Avg. Volume369,430
30 Day Avg. Volume371,606
Financial Highlights & Ratios
PEG Ratio-0.85
Price to Book (P/B)2.02
Price to Sales (P/S)1.01
P/FCF Ratio-7.94
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Accelerating Revenue GrowthRapid FY2026 revenue growth, following earlier gains, indicates improving scale and market traction across the animal health and nutrition business. If sustained, this larger revenue base can support broader distribution, operating leverage, and stronger competitive positioning over the next several quarters.
Conservative LeverageA low debt-to-equity ratio gives Ajooni financial flexibility and reduces the immediate burden of interest and refinancing obligations. This balance-sheet strength can help the company fund expansion, absorb operating volatility, and pursue growth without relying excessively on additional borrowing.
Expanded Equity BaseA materially larger equity base and positive return on equity show that the company has built shareholder capital while maintaining positive profitability. Although returns are modest and variable, this foundation can improve resilience and provide capacity to support longer-term business development.
Bears Say
Persistent Negative Operating Cash FlowFour consecutive years of negative operating cash flow indicate that reported earnings are not consistently converting into cash generated by the business. This weak cash conversion can constrain internally funded growth, increase reliance on financing, and heighten execution risk over the medium term.
Thin And Declining MarginsLow net and EBITDA margins leave limited room to absorb cost increases, pricing pressure, or operating setbacks. The downward EBITDA-margin trend also suggests that recent revenue growth has not translated proportionately into profitability, potentially limiting sustainable earnings and cash generation.
Rising Leverage DirectionAlthough leverage remains conservative, a meaningful year-over-year increase in debt warrants attention because it moves the balance sheet in a less favorable direction. If borrowing continues to rise while cash generation stays weak, financial flexibility could gradually narrow and funding risk could increase.
Ajooni Biotech Limited News
AJOONI FAQ
What was Ajooni Biotech Limited’s price range in the past 12 months?
Ajooni Biotech Limited lowest stock price was ₹3.02 and its highest was ₹5.57 in the past 12 months.
What is Ajooni Biotech Limited’s market cap?
Ajooni Biotech Limited’s market cap is ₹547.73M.
When is Ajooni Biotech Limited’s upcoming earnings report date?
Ajooni Biotech Limited’s upcoming earnings report date is Nov 06, 2026 which is in 40 days.
How were Ajooni Biotech Limited’s earnings last quarter?
Ajooni Biotech Limited released its earnings results on Aug 14, 2026. The company reported ₹0.025 earnings per share for the quarter.
Is Ajooni Biotech Limited overvalued?
According to Wall Street analysts Ajooni Biotech Limited’s price is currently Overvalued.
Does Ajooni Biotech Limited pay dividends?
Ajooni Biotech Limited does not currently pay dividends.
What is Ajooni Biotech Limited’s EPS estimate?
Ajooni Biotech Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ajooni Biotech Limited have?
Ajooni Biotech Limited has 172,243,590 shares outstanding.
What happened to Ajooni Biotech Limited’s price movement after its last earnings report?
Ajooni Biotech Limited reported an EPS of ₹0.025 in its last earnings report. Following the earnings report the stock price went up 2.387%.
Which hedge fund is a major shareholder of Ajooni Biotech Limited?
Currently, no hedge funds are holding shares in IN:AJOONI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Ajooni Biotech Limited
Founded in 2010, Ajooni Biotech Limited is an Indian enterprise primarily engaged in the production and distribution of animal nutrition products. Headquartered in Mohali, India, the company's offerings encompass specialized cattle feeds and various dietary supplements for livestock.
Technical Analysis
Avanti Feeds Limited
―
M K Proteins Limited
―
Mukka Proteins Limited
―
Parag Milk Foods Ltd.
―
SKM Egg Products Export (India) Ltd.
―